Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PADIT Pilot
NCT01613092Phase 4Completed
- Sponsor
- Population Health Research Institute
- Start
- May 2011
- Primary completion
- Nov 2013
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin, bacitracin, cefalexin, clindamycin in cardiac implantable electronic device infection (CIEDI), sponsored by Population Health Research Institute. Started May 2011; status: completed.
02
Drugs
vancomycinbacitracincefalexinclindamycin
03
Conditions
cardiac implantable electronic device infection (CIEDI)
Beyond the preview
Go deeper on NCT01613092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01613092.